All inspectors · Key sources (PDF) · STEMI shock sheet (PDF)
The STEMI with cardiogenic shock one-pagerOpen it in a new tab

The patient in front of you

Mr. R., 64, arrives in the emergency department with an anterior STEMI and is already in shock: systolic pressure in the 80s on norepinephrine, lactate rising, ejection fraction about 25% on echo. He is awake and following commands. The cath lab is being readied; the culprit artery has not yet been opened. The shock course follows him from the cath lab to the ICU; each trial answers one decision in his care.

This page helps you decide: In the emergency department, before the cath lab: a resident suggests IV metoprolol for Mr. R.'s fast heart rate. Should he get it?

After this page you can

Your routine for every trial

Work through the six steps in order. Each question at the end belongs to one step, and the answer is on that step's page.

  1. Who was studied? Which patients could enter, which could not, and how sick were they?
  2. Compared with what? What did one group get that the other did not, and what was measured?
  3. What was the main result? Both percentages, the effect size with its 95% CI, and the number needed to treat (and to harm).
  4. Any design traps? Blinding, the choice of endpoint, how close the CI comes to no effect, how long it took, who paid.
  5. Does it apply to my patient? Would my patient have been allowed into the trial?
  6. What did it change? What the guideline now says, and what the trial does not tell you.

Take-home

For Mr. R., already in shock in the emergency department, COMMIT says no intravenous metoprolol: his fast heart rate may be what is holding up his output, and early metoprolol caused one extra case of shock for every 90 patients, mostly on days 0–1. Start a beta-blocker once he has stabilized. On the one-pager it sits on page 1, in the “Why is this heart failing? — the cause” box (Iatrogenic row), and again on page 3 in “Traps that kill — or mislead”.